Management

Focused on therapeutically relevant specialty pharmaceuticals

Management

Verity Pharma has a highly qualified team of pharmaceutical business executives, and scientists with greater than 20 years of international experience in the commercial and clinical aspects of prescription medicines. Verity is also supported by globally recognized scientific, clinical and healthcare business advisers.

Mr. Howard M. Glase: CEO & General Manager

Howard brings over twenty years of Canadian and U.S. corporate pharmaceutical senior commercial management experience to Verity Pharmaceuticals. Howard has also gained experience as a CEO within the medical market... Read More

Howard brings over twenty years of Canadian and U.S. corporate pharmaceutical senior commercial management experience to Verity Pharmaceuticals. Howard has also gained experience as a CEO within the medical market research and scientific communications industries.

Acquired corporate pharmaceutical brand experiences include the launch of Cipro in Canada and Cipro IV for global markets. Additionally, Howard launched Cardizem CD in Canada and moved to the national commercial team in the USA (Sanofi) on the cardiovascular portfolio, with national responsibilities on Cardizem CD ($1.3 billion in sales) and led the launch of Teczem (Co-promoted with Merck) in the American hypertension market.

For the past 14 years, Howard has focused his entrepreneurial passion in developing healthcare businesses in the biotech and pharmaceutical industries. The successful entrepreneurial ventures included a scientific publishing business and a primary health science market research company. Howard has also been involved in providing health care consultation services to Canadian, American and Internationally based Pharmaceutical companies.

Howard studied at the University of Ottawa in Kinesiology and Health Sciences and completed a corporate-sponsored MBA certificate program in finance at Princeton University, NJ, and an executive MBA diploma course in International Business at University of Western Ontario, London, Ontario.

Read Less

Mr. Scott Doherty, CPA: Chief Financial Officer

Scott joins Verity with a background in strategic pharmaceutical planning, financial analytics, consulting, business development and tax planning within a multi national pharmaceutical organization. He achieved extensive executive decision-making accomplishments... Read More

Scott joins Verity with a background in strategic pharmaceutical planning, financial analytics, consulting, business development and tax planning within a multi national pharmaceutical organization. He achieved extensive executive decision-making accomplishments at Allergan Canada as the Senior Finance Manager, supporting senior management. During this time, Scott was responsible for overseeing the primary and specialty care business unit. Soon after, he was promoted to lead commercial analytics and planning within operations. There, his responsibilities included designing and implementing sales force compensation packages, business intelligence software, analytics and forecasting, as well as assessing ROI, resource sizing and allocation.
A CPA, Scott began his career in public accounting before becoming a senior financial analyst at a multi national traded company.

As the Verity CFO, Scott works within the Executive to contribute to the financial planning and governance of the company’s growth plans.

Read Less

Mr. Jay Silber, LLB: Chief Operating Officer and General Counsel

Jay joined Verity in 2019 as Chief Operating Officer and General Counsel and brings with him more than 13 years’ experience working with numerous multi- national clients providing guidance within... Read More

Jay joined Verity in 2019 as Chief Operating Officer and General Counsel and brings with him more than 13 years’ experience working with numerous multi- national clients providing guidance within business governance and legal initiatives. During his career, he has undertaken numerous clients, managing complex  business and negotiation positions within the Canadian market. Jay is recognized for his deep ethical sense, respect of others and talent for developing long-term business relationships. Prior to joining Verity Pharmaceuticals, Jay was a partner in a highly specialized mid-size litigation law firm, where he led numerous  business and legal initiatives.

Jay holds a Bachelor of Laws degree from the University of Windsor and a  Bachelor of Arts from Concordia University. When not in the office, Jay is involved in a number of philanthropic initiatives, is an avid reader and spends time with his wife and three daughters.

Read Less

Ms. Taniya Mann: Director of Regulatory Affairs, Quality Assurance, and Quality Control

Taniya has 20 years of experience in Canadian and Global pharmaceutical regulatory affairs. Taniya obtained her Hons. BSc in Molecular Genetics and Molecular Biology from the University of Toronto, followed... Read More

Taniya has 20 years of experience in Canadian and Global pharmaceutical regulatory affairs. Taniya obtained her Hons. BSc in Molecular Genetics and Molecular Biology from the University of Toronto, followed by a PhD in Neuropharmacology from the University of Nottingham and an MBA from Boston College.  Taniya then began pursuing her career in regulatory affairs. Her corporate background includes companies such as AstraZeneca, Boehringer Ingelheim, Apotex and Reckitt Benckiser.
She has led numerous successful filings, including NHPs, OTCs, Cosmetics, Disinfectants, Devices and Rx Drugs.  The marketing authorizations obtained have been in a number of therapeutic areas including gastrointestinal, cardiovascular, respiratory and oncology and have included biologics and generics. Taniya joins the Verity team as Director of Regulatory Affairs.

Read Less

Mr. Ostap Mojsiak: Director of Business Development and Medical Affairs

With over 30 years of Pharmaceutical Industry experience as a registered pharmacist, pharmacy business owner and pharmaceutical industry executive, Ostap joins the Verity team as Director of Business Development and... Read More

With over 30 years of Pharmaceutical Industry experience as a registered pharmacist, pharmacy business owner and pharmaceutical industry executive, Ostap joins the Verity team as Director of Business Development and Medical Affairs. Ostap gained valued experience during 9 years at GSK as the Manager of Business Development & Strategic Alliances.  His responsibilities include under taking due diligence on new product candidates, which Verity can bring to the Canadian and American marketplace as well as overseeing Medical Affairs and Medical Information for the Company.

In addition to a career primarily focused in hospital oncology pharmacy and the pharmaceutical industry, Ostap maintains a deep academic interest in new compounds and industry trends. Ostap is an active consultant as an oncology pharmacist at the Odette Cancer Centre Pharmacy at the Sunnybrook Health Sciences Centre and remains partner at the Provis Infusion Clinic, where patients have access to infusions of cancer medications.

As a pharmacist, Ostap lives by the motto: “At the End of the Day… It’s All About the Patient”.

Read Less

Mr. Scott Bradford: Director of Marketing and Communications

With over 30 years of experience in Pharmaceutical and Consumer advertising, Scott brings a high level of insight, leadership, and commitment to excellence to every assignment, no matter how big... Read More

With over 30 years of experience in Pharmaceutical and Consumer advertising, Scott brings a high level of insight, leadership, and commitment to excellence to every assignment, no matter how big or how small.

Scott spent the first 18 years of his career as Art Director and Creative Director in some of Toronto’s top agencies. The next 16 years saw him take on the world of healthcare as Partner and VP-Creative Director of Commotion Communications, leading a team of account executives, medical writers, and designers, handling pharmaceutical and medical device clients in Canada and the U.S.

From brand strategy and planning, to creative development and execution, Scott’s experiences provide him with the ability to handle the creation and marketing of a successful brand from start to finish.

Read Less

Mr. Allan Silber: Chairman

Allan C. Silber is the Chairman of Verity Pharmaceuticals, a specialty pharmaceutical company focused on therapeutically relevant agents for the Canadian health care community, whose mandate is to ensure Canadians... Read More

Allan C. Silber is the Chairman of Verity Pharmaceuticals, a specialty pharmaceutical company focused on therapeutically relevant agents for the Canadian health care community, whose mandate is to ensure Canadians have access to prescription products that have been withdrawn from the market, or are in short supply.  He is also Chairman of Heritage Global Inc., a global financial services and asset trading company providing corporate and financial asset monetization, advisory, and valuation services. Mr. Silber has an extensive background in the private equity, real-estate and financial services fields.

Allan is actively involved in a number of cultural, charitable and community-based organizations, including participation at the board level, and has been Chairman of numbers fundraising events for community-based, international organizations.  Allan is a Life Governor of The Jewish National Fund and was a Negev Dinner Honoree in recognition of his community leadership and dedicated public service.  Allan’s philanthropic initiatives include the Chair for Holocaust Studies at York University, the Silber Centre for Camping in Canada, partnering with Hillel on their talent initiative on university campuses across Ontario, partnering with JNF in Israel, responding to the social needs of the underprivileged, and focusing primarily on providing funding to enable transformative change based on goal oriented performance metrics.

Mr. Silber attended McMaster University and received a BSc from the University of Toronto.

Read Less

Mr. Robert Rieder: Member of the Board

Mr. Rieder was most recently a founder and CEO of ESSA Pharmaceuticals, and was responsible for all aspects of the business. Previously, Mr. Rieder was the CEO of Cardiome Pharma... Read More

Mr. Rieder was most recently a founder and CEO of ESSA Pharmaceuticals, and was responsible for all aspects of the business.

Previously, Mr. Rieder was the CEO of Cardiome Pharma Corp. (“Cardiome”), a public company traded on the TSX and NASDAQ. Mr. Rieder led Cardiome from the pre-clinical research stage to approval in the European Union while Cardiome negotiated partnerships with Merck and Astellas. Mr. Rieder has been a director for nine public and private technology companies. He has raised over $250Million in his career. In 2009, he was acknowledged as “Executive of the Year” by Life Sciences B.C. and in 2007 was named Ernst & Young “Entrepreneur of the Year” for the Medical Products area in the Pacific Region.

Read Less